News

Keeping you current on new and follow-on investments, portfolio product and service milestones, publications and events, management and board transitions, and other developments in Tullis funds.

June

27

TriSalus Life Sciences forms World-Class Scientific Advisory Board to Accelerate Advancement of Strategy to Deliver Therapeutics to Solid Tumors

New Board compromised of preeminent experts across medical, surgical and radiation oncology, as well...

24

ElectroCore Announces GammaCore Listing on the NHS Supply Chain Catalogue

Provides UK-based primary headache patients not eligible for the Innovation Technology Payment scheme (reserved...

19

SupplyPro Feautured in Technology Headlines Magazine’s May 2019 Issue

10 Fastest growing inventory management solution providers to watch in 2019 http://www.supplypro.com/Content/pdfs/Inventory_CoverStory.pdf...

30

AlphaTec Announces Commercial Launch of TLIF IndentiTi™ Posterior Curved Porous Titanium Interbody Implant System

Innovative machine marks the fourth of twelve new product launches planned for 2019, and...

20

UCB announces NAYZILAM® (midazolam) nasal spray now approved by FDA to treat intermittent, stereotypic episodes of frequent seizure activity in people living with epilepsy in the U.S.

– NAYZILAM® (midazolam) nasal spray CIV is a nasally administered benzodiazepine indicated for the...

24

Exagen’s New Biomarker Available to Offer Insight into Thrombosis for Lupus Sufferers

Lupus patients with elevated PC4d Levels have significantly increased occurrence of Thrombosis SAN DIEGO,...

15

AlphaTec Announces Sales Leadership Appointment and Succesful Closing of Expanded Credit Facility with Squadron Capital

Experienced spine executive David Sponsel assumes sales leadership role CARLSBAD, Calif., April 15, 2019 (GLOBE NEWSWIRE)...

28

AlphaTec Announces Commercial Launch of its First IndentiTi™ Porous Titanium Interbody System

IndetiTi implants are 60% porous, which enhances intra-operative and post-operative imaging CARLSBAD, Calif., March 28,...

27

ElectroCore Announces Fourth Quarter and Full Year 2018 Financial Results

Fourth quarter 2018 prescription growth of more than 30% from third quarter 2018 BASKING...

26

Jeffrey Thomas Elliott, CFA Joins Exagen’s Board of Directors

Jeff Elliot adds relevant experience to Exagen’s Board of Directors as a former diagnostics...

14

ElectroCore Announces Encouraging Research Supporting Key Areas of Clinical Development for its non-invasive Vagus Nerve Stimulator, GammaCore™

Data presented at the 3rd International Brain Stimulation Conference support the use of nVNS...

8

ElectroCore Appoints Multiple Industry Veterans to Key Management Positions

Dr. Tony Florino to serve as Chief Medical Officer and Brian Posner as Chief...